Your browser doesn't support javascript.
loading
Drugging the Undruggable: How Isoquinolines and PKA Initiated the Era of Designed Protein Kinase Inhibitor Therapeutics.
Lorenz, Robin; Wu, Jian; Herberg, Friedrich W; Taylor, Susan S; Engh, Richard A.
Affiliation
  • Lorenz R; Department of Biochemistry, Institute for Biology, University of Kassel, Kassel 34132, Germany.
  • Wu J; Department of Pharmacology, University of California, San Diego, 9400 Gilman Drive, La Jolla, California 92093-0654, United States.
  • Herberg FW; Department of Biochemistry, Institute for Biology, University of Kassel, Kassel 34132, Germany.
  • Taylor SS; Department of Pharmacology, University of California, San Diego, 9400 Gilman Drive, La Jolla, California 92093-0654, United States.
  • Engh RA; Department of Chemistry and Biochemistry, University of California, San Diego, 9400 Gilman Drive, La Jolla, California 92093-0654, United States.
Biochemistry ; 60(46): 3470-3484, 2021 11 23.
Article in En | MEDLINE | ID: mdl-34370450
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Cyclic AMP-Dependent Protein Kinases / Protein Kinase Inhibitors Type of study: Prognostic_studies Language: En Journal: Biochemistry Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Cyclic AMP-Dependent Protein Kinases / Protein Kinase Inhibitors Type of study: Prognostic_studies Language: En Journal: Biochemistry Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United States